Laseroptek Co., Ltd.
Research Laseroptek Co., Ltd. (199550.KQ) on Bullrun: market cap KRW 44.46B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker199550.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Devices
- CurrencyKRW
- Market capKRW 44.46B
- Financial periodQ2 2026
- RevenueKRW 8.79B
- Net income-KRW 772.47M
- Free cash flowKRW 952.49M
- Gross margin42.7%
Valuation Snapshot
latest market cap is KRW 44.46B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 44.46B | n/a | n/a | n/a |
Dividend history
About Laseroptek Co., Ltd.
Laseroptek Co., Ltd. develops and manufactures aesthetic and medical laser devices in South Korea. Its laser devices perform aesthetic and medical dermatological treatments for a range of indications, such as benign pigmentation lesions, fine lines and wrinkles, scar revision, skin rejuvenation and lifting, hair removal, vascular lesions, vitiligo, psoriasis, atopic dermatitis, leukoderma, and alopecia areata. The company was founded in 2000 and is based in Seongnam-si, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Laseroptek Co., Ltd.'s market cap?
Laseroptek Co., Ltd.'s market capitalization is KRW 44.46B.
What does Laseroptek Co., Ltd. do?
Laseroptek Co., Ltd. develops and manufactures aesthetic and medical laser devices in South Korea. Its laser devices perform aesthetic and medical dermatological treatments for a range of indications, such as benign pigmentation lesions, fine lines and wrinkles, scar revision, skin rejuvenation and lifting, hair removal, vascular lesions, vitiligo, psoriasis, atopic dermatitis, leukoderma, and alopecia areata. The company was founded in 2000 and is based in Seongnam-si, South Korea.